secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cingulate Inc. (CING)
CIK:        0001862150
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0001493152-24-051196
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cingulate raises $5M via 9% promissory note; cash runway into Q4 2025, NDA target mid-2025
--------------------------------------------------------------------------------

- Net proceeds of $5.0M from $5.48M unsecured note (9% interest, 18-month maturity, $450K OID).
- Cash runway extended to Q4 2025; NDA submission for CTx-1301 targeted for mid-2025.
- Lender Streeterville Capital; monthly redemption cap $550K from July 2025; default triggers 15%/5% balance increases.
- Guarantees from subsidiaries Cingulate Therapeutics LLC and Cingulate Works, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1862150/000149315224051196/0001493152-24-051196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1862150/000149315224051196/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-051196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer